Zdrowie i gospodarka · 19/12/1997

FDA Revokes Guidance Documents on PET Drug Products

The Food and Drug Administration (FDA) is revoking two notices regarding guidance documents affecting positron emission tomography (PET) radiopharmaceutical drug products, which address FDA's regulatory approach and current good manufacturing practice requirements, in accordance with the Food and Drug Administration Modernization Act of 1997.